Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

China Pacific Insurance - H (2601.HK)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (HK$) Price Target (HK$) Rating
2021-08-1322.6537.00Buy
2021-08-1823.4029.00Buy
2022-01-1723.1527.60Buy
2022-03-0919.9427.20Buy
2022-03-2818.9226.60Buy
2022-04-2917.5625.00Buy
2022-08-0416.0623.00Buy
2022-10-2812.2821.20Buy
2023-01-1820.8027.20Buy
2023-03-2720.2027.30Buy
2023-05-0323.4029.30Buy
2023-10-3119.2826.00Buy
2024-02-2715.6024.00Buy
2024-10-1627.8033.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.